Emdeon Announces Billing Solution for H1N1 Vaccine Administration

Electronic alternative to paper billing helps to connect retail pharmacies with the nation's top 25 medical payers in real-time


NASHVILLE, Tenn., Nov. 4  /PRNewswire-FirstCall/ -- Emdeon® (NYSE:EM), a leading provider of healthcare revenue and payment cycle management solutions, today announced that its eRx Network® will provide real-time electronic billing solutions to retail pharmacies for the nation's top 25 medical payers in light of the dramatic increase in H1N1 vaccinations being administered by pharmacies. The Center for Disease Control and Prevention predicts 10-12 million doses of the H1N1 vaccination will be available by the end of October and many of these vaccinations will be administered by retail pharmacies.

Retail pharmacies and other mass vaccination organizations often lack the ability to bill medical claims electronically and thus submit claims on paper to the paying health plan. While the vaccine itself is provided at no charge, administration of the H1N1 vaccine is a medical procedure reimbursable under the medical benefits of many health plans.

"This is the first time in many years that the healthcare industry has faced a real-world pandemic and we are able to rise to that need with a real-time, electronic solution that will help pharmacies process medical claims efficiently," said Mark Lyle, senior vice president for eRx Network pharmacy services at Emdeon.

The Emdeon eRx Network solution enables both new and existing retail pharmacy customers to submit these medical services for reimbursement to health plans in a standard electronic pharmacy claim. The medical claim will then be delivered to the payer and processed through their standard reimbursement cycle. Ultimately, Emdeon will help to facilitate the claim processing and the health plan will potentially avoid expensive, manual workload associated with paper claim submission.

"By providing the marketplace with innovative solutions, Emdeon continues to demonstrate the value of having one partner in the healthcare industry to address market opportunities," said George Lazenby, chief executive officer of Emdeon. "This timely solution is an example of combining Emdeon's broad connectivity in both the pharmacy and payer markets to simplify the business of healthcare," Lazenby continued.

In addition to the solutions being provided to eRx Network customers, other Emdeon customers that utilize Emdeon Office(TM), a multi-payer portal for healthcare revenue cycle management, also are able to process claims for H1N1 vaccination administration electronically. Emdeon Office allows these providers to verify insurance eligibility for more than 500 payers nationally, submit and track claims, and manage any changes to those claims through a web-based interface.

About Emdeon®

Emdeon (NYSE:EM) is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon's product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon's comprehensive suite of products and services, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. For more information, visit http://www.emdeon.com/.

Statements made in this press release that express Emdeon's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which Emdeon intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Forward-looking statements may include information concerning Emdeon's possible or assumed future results of operations, including descriptions of Emdeon's revenues, profitability and outlook for 2009 and its overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to Emdeon's operations and business environment, all of which are difficult to predict and many of which are beyond Emdeon's control. Although Emdeon believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Emdeon's actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including the risks discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and elsewhere in Emdeon's Registration Statement on Form S-1 and the accompanying Prospectus thereto, as filed with the SEC, as well as Emdeon's periodic reports filed with the SEC and other public filings of Emdeon.

You should keep in mind that any forward-looking statement made by Emdeon herein, or elsewhere, speaks only as of the date on which made. Emdeon expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in Emdeon's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. 

DATASOURCE: Emdeon



CONTACT:  Amanda Woodhead, media contact of Emdeon, [phone],

, or Tommy Lewis, Investor Relations Contact of Emdeon,

[phone], 



Web Site:  http://www.emdeon.com/ 

Copyright